Emerging Growth News
Milestone Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Its Initial Public Offering
|
MONTREAL and CHARLOTTE, N.C., May 14, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of
Emerging Growth News
Away is Valued at $1.4 Billion After a Series D Investment of $100 Million
|
NEW YORK, May 14, 2019 /PRNewswire/ -- Away, the direct-to-consumer travel brand that launched 3 years ago, today announced the close of a $100 million Series D investment round. The